Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O- gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB

Apoptosis

Volumn 16, Issue 1, 2011, Pages 75-85

  Lee, Mi Hee ^a   Han, Dong Wook ^b   Hyon, Suong Hyu ^c   Park, Jong Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspases; Epigallocatechin 3 O gallate; Human fibrosarcoma cells; Nuclear factor B; p53

Indexed keywords

CASPASE; CASPASE 7; CASPASE 9; EPIGALLOCATECHIN GALLATE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SYNAPTOTAGMIN I; TEAVIGO; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CYTOSOL; DNA FRAGMENTATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSARCOMA; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CATECHIN; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; FIBROSARCOMA; GENE EXPRESSION; HUMANS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 79951551609     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0548-y     Document Type: Article

References (49)

1. WJ Blot WH Chow JK McLaughlin 1996 Tea and cancer: a review of the epidemiological evidence Eur J Cancer Prev 5 425 438 1:STN:280: DyaK2s3hsV2jug%3D%3D 9061273 (Pubitemid 27087365)
2. DE Brash PA Havre 2002 New careers for antioxidants Proc Natl Acad Sci USA 99 13969 13971 1:CAS:528:DC%2BD38XosF2isLg%3D 10.1073/pnas.232574399 12391310 (Pubitemid 35257608)
3. N Khan F Afaq M Saleem N Ahmad H Mukhtar 2006 Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate Cancer Res 66 2500 2505 1:CAS:528:DC%2BD28XhvV2htrc%3D 10.1158/0008-5472.CAN-05-3636 16510563
4. Z Hou S Sang H You, et al. 2005 Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells Cancer Res 65 8049 8056 1:CAS:528:DC%2BD2MXpslahsL0%3D 10.1158/0008-5472.CAN-05-2004 16140980 (Pubitemid 41541481)
5. YP Lu YR Lou JG Xie, et al. 2002 Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice Proc Natl Acad Sci USA 99 12455 12460 1:CAS:528:DC%2BD38XntlCktrc%3D 10.1073/pnas.182429899 12205293
6. AM Roy MS Baliga SK Katiyar 2005 Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation Mol Cancer Ther 4 81 90 1:CAS:528:DC%2BD2MXksF2hug%3D%3D 15657356 (Pubitemid 40268069)
7. K Hastak S Gupta N Ahmad MK Agarwal ML Agarwal H Mukhtar 2003 Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells Oncogene 22 4851 4859 1:CAS:528:DC%2BD3sXlvVKgu7c%3D 10.1038/sj.onc.1206708 12894226 (Pubitemid 36981273)
8. JT Hwang J Ha IJ Park, et al. 2007 Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway Cancer Lett 247 115 121 1:CAS:528:DC%2BD2sXht1elsQ%3D%3D 10.1016/j.canlet.2006.03.030 16797120 (Pubitemid 46001507)
9. PP Wu SC Kuo WW Huang, et al. 2009 (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway Anticancer Res 29 1435 1442 1:CAS:528: DC%2BD1MXltFCgsb0%3D 19414399
10. MW Roomi JC Monterrey T Kalinovsky M Rath A Niedzwiecki 2010 Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines Oncol Rep 24 747 757 1:CAS:528: DC%2BC3cXhtFSkt7%2FI 20664983
11. I Dell'Aica M Donà L Sartor E Pezzato S Garbisa 2002 (-)Epigallocatechin-3-gallate directly inhibits MT1-MMP activity, leading to accumulation of nonactivated MMP-2 at the cell surface Lab Invest 82 1685 1693 12480918 (Pubitemid 35462981)
12. M Maeda-Yamamoto N Suzuki Y Sawai, et al. 2003 Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells J Agric Food Chem 51 1858 1863 1:CAS:528: DC%2BD3sXhtlCjtrY%3D 10.1021/jf021039l 12643642
13. MH Kim MA Jung YS Hwang, et al. 2004 Regulation of urokinase plasminogen activator by epigallocatechin-3-gallate in human fibrosarcoma cells Eur J Pharmacol 487 1 6 1:CAS:528:DC%2BD2cXitFeiur8%3D 10.1016/j.ejphar.2003.12.031 15033370 (Pubitemid 38368976)
14. KR Landis-Piwowar C Huo D Chen, et al. 2007 A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent Cancer Res 67 4303 4310 1:CAS:528:DC%2BD2sXltVyrsLo%3D 10.1158/0008-5472.CAN-06- 4699 17483343 (Pubitemid 46815078)
15. J Qin HG Chen Q Yan, et al. 2008 Protein phosphatase-2A is a target of epigallocatechin-3-gallate and modulates p53-Bak apoptotic pathway Cancer Res 68 4150 4162 1:CAS:528:DC%2BD1cXmsFKmtLk%3D 10.1158/0008-5472.CAN-08-0839 18519674
16. K Hastak MK Agarwal H Mukhtar ML Agarwal 2005 Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate FASEB J 19 789 791 1:CAS:528:DC%2BD2MXktVKmsLk%3D 15764647 (Pubitemid 40617385)
17. S Azam N Hadi NU Khan SM Hadi 2004 Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties Toxicol In Vitro 18 555 561 1:CAS:528:DC%2BD2cXls1Wlsr0%3D 10.1016/j.tiv.2003.12.012 15251172 (Pubitemid 38900862)
18. Y Zhao LF Yang M Ye HH Gu Y Cao 2004 Induction of apoptosis by epigallocatechin-3-gallate via mitochondrial signal transduction pathway Prev Med 39 1172 1179 1:CAS:528:DC%2BD2cXpslCqs7s%3D 10.1016/j.ypmed.2004.04.042 15539052 (Pubitemid 39480669)
19. LA Smets 1994 Programmed cell death (apoptosis) and response to anticancer drugs Anticancer Drugs 5 3 9 1:CAS:528:DyaK2cXjtFCqtbY%3D 10.1097/00001813-199402000-00001 8186426 (Pubitemid 24066555)
20. D-W Han K Matsumura B Kim S-H Hyon 2008 Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells Bioorg Med Chem 16 9652 9659 1:CAS:528:DC%2BD1cXhtlaqu73M 10.1016/j.bmc.2008.10. 009 18951028
21. H Tachibana K Koga Y Fujimura K Yamada 2004 A receptor for green tea polyphenol EGCG Nat Struct Mol Biol 11 380 381 1:CAS:528:DC%2BD2cXisFCitLc%3D 10.1038/nsmb743 15024383 (Pubitemid 38436804)
22. D Umeda S Yano K Yamada H Tachibana 2008 Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor J Biol Chem 283 3050 3058 1:CAS:528:DC%2BD1cXhtlyjs7Y%3D 10.1074/jbc.M707892200 18079119
23. S Singer JM Corson GD Demetri EA Healey K Marcus TJ Eberlein 1995 Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma Ann Surg 221 185 195 1:STN:280:DyaK2M7mtVGnuw%3D%3D 10.1097/00000658-199502000-00009 7857146
24. E Donato Di Paola OS Nielsen 2002 The EORTC soft tissue and bone sarcoma group Eur J Cancer 38 S138 S141 10.1016/S0959-8049(01)00444-0 11858980
25. A Daigeler C Brenzel D Bulut, et al. 2008 TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma J Exp Clin Cancer Res 27 82 10.1186/1756-9966-27-82 19077262
26. JK Kundu YJ Surh 2008 Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives Cancer Lett 269 243 261 1:CAS:528:DC%2BD1cXhtFWlsrjO 10.1016/j.canlet.2008.03.057 18550275
27. DR Green GI Evan 2002 A matter of life and death Cancer Cell 1 19 30 1:CAS:528:DC%2BD38XitlCmsLc%3D 10.1016/S1535-6108(02)00024-7 12086884 (Pubitemid 41039172)
28. SY Sun 2005 Chemopreventive agent-induced modulation of death receptors Apoptosis 10 1203 1210 1:CAS:528:DC%2BD28XmsFCksw%3D%3D 10.1007/s10495-005-2274- 4 16215675 (Pubitemid 43117669)
29. SL Harris AJ Levine 2005 The p53 pathway: positive and negative feedback loops Oncogene 24 2899 2908 1:CAS:528:DC%2BD2MXjtlehs7c%3D 10.1038/sj.onc. 1208615 15838523 (Pubitemid 40638098)
30. C Papazoglu AA Mills 2007 p53: at the crossroad between cancer and ageing J Pathol 211 124 133 1:CAS:528:DC%2BD2sXisFyksbk%3D 10.1002/path.2086 17200941 (Pubitemid 46195511)
31. L Lahiry B Saha J Chakraborty, et al. 2008 Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis Apoptosis 13 771 781 1:CAS:528:DC%2BD1cXlvFaisrY%3D 10.1007/s10495-008-0213-x 18454316
32. T Miyashita JC Reed 1995 Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 293 299 1:CAS:528:DyaK2MXjtlGns7w%3D 10.1016/0092-8674(95)90513-8 7834749
33. S Haldar M Negrini M Monne S Sabbioni CM Croce 1994 Down-regulation of bcl-2 by p53 in breast cancer cells Cancer Res 54 2095 2097 1:CAS:528: DyaK2cXis1OjtbY%3D 8174112 (Pubitemid 24138678)
34. A Frenzel F Grespi W Chmelewskij A Villunger 2009 Bcl2 family proteins in carcinogenesis and the treatment of cancer Apoptosis 14 584 596 1:CAS:528:DC%2BD1MXivFSns7o%3D 10.1007/s10495-008-0300-z 19156528
35. M Tarunina JR Jenkins 1993 Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity Oncogene 8 3165 3173 1:CAS:528:DyaK2cXkvVeksA%3D%3D 8414520 (Pubitemid 23312925)
36. M Karin Y Cao FR Greten ZW Li 2002 NF-κB in cancer: from innocent by stander to major culprit Nat Rev Cancer 2 301 310 1:CAS:528: DC%2BD38XivFGqt7k%3D 10.1038/nrc780 12001991 (Pubitemid 37328783)
37. DA Mann F Oakley 2005 NF-κB: a signal for cancer J Hepatol 42 610 611 10.1016/j.jhep.2005.01.007 16715553 (Pubitemid 40342946)
38. J Dutta Y Fan N Gupta G Fan C Gélinas 2006 Current insights into the regulation of programmed cell death by NF-κB Oncogene 25 6800 6816 1:CAS:528:DC%2BD28XhtFekt7fP 10.1038/sj.onc.1209938 17072329 (Pubitemid 44657853)
39. SH Lee CW Lee JW Lee, et al. 2005 Induction of apoptotic cell death by 2'-hydroxycinnamaldehyde is involved with ERK-dependent inactivation of NF-κB in TNF-α-treated SW620 colon cancer cells Biochem Pharmacol 70 1147 1157 1:CAS:528:DC%2BD2MXhtVWnsLzI 10.1016/j.bcp.2005.07.028 16143316 (Pubitemid 41317509)
40. A Yemelyanov A Gasparian P Lindholm, et al. 2006 Effects of IKK inhibitor PS1145 on NF-κB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells Oncogene 25 387 398 1:CAS:528:DC%2BD28Xlt1egtw%3D%3D 16170348 (Pubitemid 43117624)
41. L Vermeulen G DeWilde S Notebaert W Vanden Berghe G Haegeman 2002 Regulation of the transcriptional activity of the nuclear factor κB p65 subunit Biochem Pharmacol 64 963 970 1:CAS:528:DC%2BD38Xms1ymsLw%3D 10.1016/S0006-2952(02)01161-9 12213593 (Pubitemid 35232270)
42. RJ Youle A Strasser 2008 The BCL-2 protein family: opposing activities that mediate cell death Nat Rev Mol Cell Biol 9 47 59 1:CAS:528: DC%2BD2sXhsVKrsrrP 10.1038/nrm2308 18097445
43. G Kroemer J Reed 2000 Mitochondrial control of cell death Nat Med 6 513 519 1:CAS:528:DC%2BD3cXjtFyhsL4%3D 10.1038/74994 10802706 (Pubitemid 30305900)
44. MS Soengas RM Alarcón H Yoshida, et al. 1999 Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition Science 284 156 159 1:CAS:528:DyaK1MXitlClu7w%3D 10.1126/science.284.5411.156 10102818 (Pubitemid 29282071)
45. S Okabe M Suganuma M Hayashi E Sueoka A Komori H Fujiki 1997 Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols Jpn J Cancer Res 88 639 643 1:CAS:528:DyaK2sXltlSrtL0%3D 9310136 (Pubitemid 27394047)
46. J Hong H Lu X Meng JH Ryu Y Hara CS Yang 2002 Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells Cancer Res 62 7241 7246 1:CAS:528:DC%2BD3sXhtVyqtw%3D%3D 12499265 (Pubitemid 36025245)
47. T Kuzuhara Y Sei K Yamaguchi M Suganuma H Fujiki 2006 DNA and RNA as new binding targets of green tea catechins J Biol Chem 281 17446 17456 1:CAS:528:DC%2BD28XlvVGktLs%3D 10.1074/jbc.M601196200 16641087
48. CJ Gruber W Tschugguel C Schneeberger JC Huber 2002 Production and actions of estrogens N Engl J Med 346 340 352 1:CAS:528:DC%2BD38XpsVykug%3D%3D 10.1056/NEJMra000471 11821512 (Pubitemid 34438843)
49. JY Bae J Kanamune D-W Han K Matsumura S-H Hyon 2009 Reversible regulation of cell cycle-related genes by epigallocatechin gallate for hibernation of neonatal human tarsal fibroblasts Cell Transpl 18 459 469 10.3727/ 096368909788809776